Attachment 3 Chronic Kidney Disease Gene Panel List.xlsx
XLSX spreadsheet 21 KB Posted
- Attached to
- Q301--Chronic Kidney Disease Gene Panel Test Federal contract opportunity
- Solicitation number
- 36C24823Q0231
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 36C24823Q0231 0002.docx | DOCX document | |
| 36C24823Q0231 0001.docx | DOCX document | |
| Attachment 2. CKD Statement of Work.pdf | ||
| 36C24823Q0231.docx | DOCX document | |
| Attachment 1. FAR 52.212-1 Instructions to Offerors.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| Condition Name | Gene |
| 17-Alpha-Hydroxylase 17/20 -Lyase Deficiency | CYP17A1 |
| 5-Oxoprolinase De�ciency | OPLAH |
| Acroosteolysis, Dominant | NOTCH2 |
| Acro-Renal-Ocular Syndrome | SALL4 |
| Adenine Phosphoribosyltransferase Deficiency | APRT |
| Alagille Syndrome, Type 1, 2 | JAG1 |
| Alagille Syndrome, Type 1, 2 | NOTCH2 |
| Alkaptonuria | HGD |
| Alport Syndrome | COL4A3 |
| Alport Syndrome | COL4A4 |
| Alport Syndrome | COL4A5 |
| Alstrom Syndrome | ALMS1 |
| Amelogenesis Imperfecta Type 1G, 2A3 | FAM20A |
| Amelogenesis Imperfecta Type 1G, 2A3 | WDR72 |
| Amyloidosis | APOA1 |
| Amyloidosis | APOC2 |
| Amyloidosis | B2M |
| Amyloidosis | GSN |
| Amyloidosis | LYZ |
| Amyloidosis | TTR |
| Antley-Bixler Syndrome | FGFR2 |
| Apert Syndrome | FGFR2 |
| Apparent Mineralocorticoid Excess | HSD11B2 |
| Arthrogryposis, Cleft Palate, Craniosynostosis, and Impaired Intellectual Development | PPP3CA |
| Atypical hemolytic uremic syndrome (aHUS) | CFH |
| Atypical hemolytic uremic syndrome (aHUS) | CFHR5 |
| Atypical hemolytic uremic syndrome (aHUS) | CFI |
| Atypical hemolytic uremic syndrome (aHUS) | THBD |
| Atypical hemolytic uremic syndrome (aHUS) | DGKE |
| Atypical hemolytic uremic syndrome (aHUS) | C3 |
| Atypical hemolytic uremic syndrome (aHUS) | PLG |
| Autoinflammation, Antibody Deficiency, and Immune Dysregulation Syndrome | PLCG2 |
| Axenfeld-Rieger Syndrome, Type 3 | FOXC1 |
| Baraitser-Winter Syndrome, Type 1 | ACTB |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | ARL6 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBIP1 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBS1 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBS10 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBS12 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBS2 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBS4 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBS5 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBS7 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | BBS9 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | C8ORF37 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | CEP290 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | LZTFL1 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | MKKS |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | SDCCAG8 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | TRIM32 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | TTC8 |
| Bardet-Biedl Syndromes, Type 1-12, 14-18, 21 | WDPCP |
| Bartter Syndrome, Type 1, 2, 3/4B, 4a | BSND |
| Bartter Syndrome, Type 1, 2, 3/4B, 4a | CLCNKB |
| Bartter Syndrome, Type 1, 2, 3/4B, 4a | KCNJ1 |
| Bartter Syndrome, Type 1, 2, 3/4B, 4a | SLC12A1 |
| Beckwith-Wiedemann Syndrome | CDKN1C |
| Beckwith-Wiedemann Syndrome | NSD1 |
| Beta-Hemoglobinopathies | HBB |
| Bifid Nose with or without Anorectal and Renal Anomalies | FREM1 |
| Birt-Hogg-Dube Syndrome | FLCN |
| Bladder Dysfunction, Autonomic, with Impaired Pupillary Reflex and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) | CHRNA3 |
| Branchiooculofacial Syndrome | TFAP2A |
| Branchio-Oto-Renal Syndrome, Type 1, 2 | SIX1 |
| Branchio-Oto-Renal Syndrome, Type 1, 2 | EYA1 |
| Branchio-Oto-Renal Syndrome, Type 1, 2 | SIX5 |
| Burn-McKeown Syndrome | TXNL4A |
| C3 Glomerulopathy | C3 |
| C3 Glomerulopathy | CFHR5 |
| C3 Glomerulopathy | CFI |
| C3 Glomerulopathy | CFH |
| C3 Glomerulopathy | DGKE |
| Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) | BMP4 |
| Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) | BMP7 |
| Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) | CHD1L |
| Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) | CRKL |
| Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) | GDNF |
| Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) | GREM1 |
| Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) | ROBO2 |
| Cardiofaciocutaneous Syndrome | KRAS |
| Carnitine Palmitoyltransferase 2 Deficiency | CPT2 |
| Cataract, Juvenile, with Microcornia and Glucosuria | SLC16A12 |
| Cenani-Lenz Syndactyly Syndrome | LRP4 |
| Cerebral Creatine Deficiency Syndrome 3 | GATM |
| Pulmonary Venoocclusive Disease 1 | INF2 |
| CHARGE Syndrome | CHD7 |
| CHARGE Syndrome | SEMA3E |
| CHILD Syndrome | CHILD Syndrome |
| Chondrodysplasia Punctata | EBP |
| Ciliopathies, RPGRIP1L-Related | RPGRIP1L |
| COACH Syndrome | TMEM67 |
| Coenzyme Q10 Deficiency, Primary, Type 1, 2, 3, 6 | COQ2 |
| Coenzyme Q10 Deficiency, Primary, Type 1, 2, 3, 6 | COQ6 |
| Coenzyme Q10 Deficiency, Primary, Type 1, 2, 3, 6 | PDSS1 |
| Coenzyme Q10 Deficiency, Primary, Type 1, 2, 3, 6 | PDSS2 |
| Combined Oxidative Phosphorylation Deficiency, Type 11 | RMND1 |
| Complement Component 5 Deficiency | C5 |
| Complement Factor H, I De�ciency | CFH |
| Complement Factor H, I De�ciency | CFI |
| Congenital Adrenal Hyperplasia due to 3-Beta-Hydroxysteroid Dehydrogenase Deficiency and 11-Beta-Hydroxylase Deficiency | CYP11B1 |
| Congenital Adrenal Hyperplasia due to 3-Beta-Hydroxysteroid Dehydrogenase Deficiency and 11-Beta-Hydroxylase Deficiency | HSD3B2 |
| Congenital Adrenal Hypoplasia with Hypogonadotropic Hypogonadism | NR0B1 |
| Congenital Anomalies of the Kidney and Urinary Tract Syndrome with or without Hearing Loss, Abnormal Ears, or Developmental Delay (CAKUTHED | PBX1 |
| Congenital Disorder of Glycosylation, Type 1A, 1H, 1K, 1L | ALG1 |
| Congenital Disorder of Glycosylation, Type 1A, 1H, 1K, 1L | ALG8 |
| Congenital Disorder of Glycosylation, Type 1A, 1H, 1K, 1L | ALG9 |
| Congenital Disorder of Glycosylation, Type 1A, 1H, 1K, 1L | PMM2 |
| Congenital Hyperinsulinism | KCNJ11 |
| Cornelia de Lange Syndrome | SMC1A |
| Corticosterone Methyloxidase Deficiency | CYP11B2 |
| Cranioectodermal Dysplasia, Type 1, 3 | IFT122 |
| Cranioectodermal Dysplasia, Type 1, 3 | IFT43 |
| Cranioectodermal Dysplasia, Type 1, 3 | WDR19 |
| Currarino Syndrome | MNX1 |
| CYP11A1 De�ciency Syndrome | CYP11A1 |
| Cystinosis | CTNS |
| Cystinuria | SLC3A1 |
| Cystinuria | SLC7A9 |
| Dent Disease | CLCN5 |
| Dent Disease | OCRL |
| Denys-Drash Syndrome | WT1 |
| Diabetes Insipidus, Nephrogenic | AQP2 |
| Diabetes Insipidus, Nephrogenic | AVPR2 |
| Diabetes insipidus, Neurohypophyseal Diabetes Mellitus | AVP |
| Diabetes insipidus, Neurohypophyseal Diabetes Mellitus | GCK |
| Diabetes insipidus, Neurohypophyseal Diabetes Mellitus | HNF1A |
| Diabetes insipidus, Neurohypophyseal Diabetes Mellitus | PAX4 |
| Diabetes Mellitus, Juvenile-Onset | PCBD1 |
| Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism | GLIS3 |
| Diabetes Mellitus, Noninsulin-Dependent | SLC2A2 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPL11 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPL26 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPL35A |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPL5 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPS10 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPS17 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPS19 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPS24 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPS26 |
| Diamond-Blackfan Anemia,Type 1, 3-11 | RPS7 |
| Donnai-Barrow Syndrome | LRP2 |
| Duane-Radial Ray Syndrome | SALL4 |
| Eagle-Barrett Syndrome | CHRM3 |
| Ectrodactyly, Ectodermal Dysplasia,and Cleft Lip/Palate Syndrome 3 | TP63 |
| Encephalocraniocutaneous Lipomatosis | FGFR1 |
| Epilepsy, Progressive Myoclonic, 4 with or without Renal Failure | SCARB2 |
| Epstein Syndrome | MYH9 |
| Fabry Disease | GLA |
| Familial Cold-Induced In�ammatory Syndrome, Type 1, 3 | NLRP3 |
| Familial Cold-Induced In�ammatory Syndrome, Type 1, 3 | PLCG2 |
| Familial Dysautonomia, Hereditary Sensory and Autonomic Neuropathy Type 3 | ELP1 |
| Familial Mediterranean Fever | MEFV |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCA |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCB |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCC |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCD2 |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCE |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCF |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCG |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCI |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCL |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | FANCM |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | PALB2 |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | RAD51C |
| Fanconi Anemia, Group A, B, C, D2, E, F, G, I, L, M, N, O, P | SLX4 |
| Fanconi Renotubular Syndrome, Type 1, 2, 4 | GATM |
| Fanconi Renotubular Syndrome, Type 1, 2, 4 | HNF4A |
| Fanconi Renotubular Syndrome, Type 1, 2, 4 | SLC34A1 |
| Fanconi-Bickel Syndrome | SLC2A2 |
| Fechtner Syndrome | MYH9 |
| Feingold Syndrome | MYCN |
| Floating-Harbor Syndrome | SRCAP |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | ACTN4 |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | ALG13 |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | APOL1 |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | CD2AP |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | INF2 |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | MYO1E |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | PAX2 |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | PMM2 |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | SYNPO |
| Focal Segmental ACTN4 Glomerulosclerosis, Type 2, 4, 5, 6, 7 | TRPC6 |
| Fraser Syndrome | FRAS1 |
| Fraser Syndrome | FREM2 |
| Fraser Syndrome | GRIP1 |
| Fraser Syndrome | WT1 |
| Galloway-Mowat Syndrome | TP53RK |
| Galloway-Mowat Syndrome | WDR73 |
| Genitopatellar Syndrome | KAT6B |
| Gillessen Kaesbach Nishimura Syndrome (GIKANIS) | ALG9 |
| Gitelman Syndrome | SLC12A3 |
| Glomerulocystic Kidney Disease | HNF1B |
| Glomerulocystic Kidney Disease | REN |
| Glomerulocystic Kidney Disease | UMOD |
| Glomerulopathy with Fibronectin Deposits 2 | FN1 |
| Glucocorticoid Resistance, Generalized | NR3C1 |
| Glycogen Storage Disease, Type 1A, 1B/1C, 11 | G6PC |
| Glycogen Storage Disease, Type 1A, 1B/1C, 11 | LDHA |
| Glycogen Storage Disease, Type 1A, 1B/1C, 11 | SLC37A4 |
| Golabi-Behmel Syndrome, Type 2 | OFD1 |
| Hajdu-Cheney Syndrome | NOTCH2 |
| Hand-Foot-Uterus Syndrome | HOXA13 |
| Hartnup Disorder | SLC6A19 |
| Hereditary Angiopathy with Nephropathy, Aneurysms and Muscle Cramps (HANAC) | COL4A1 |
| Hereditary Renal Amyloidosis | FGA |
| Hermansky-Pudlak Syndrome 1 | HPS1 |
| Hyperaldosteronism, Familial, Type 1, 2, 3, 4 | CACNA1H |
| Hyperaldosteronism, Familial, Type 1, 2, 3, 4 | CLCN2 |
| Hyperaldosteronism, Familial, Type 1, 2, 3, 4 | CYP11B1 |
| Hyperaldosteronism, Familial, Type 1, 2, 3, 4 | CYP11B2 |
| Hyperaldosteronism, Familial, Type 1, 2, 3, 4 | KCNJ5 |
| Hypercalcemia Infantile, Type 1, 2 | CYP24A1 |
| Hypercalcemia Infantile, Type 1, 2 | SLC34A1 |
| Hypercalciuria, Hypophosphatemic Rickets | ADCY10 |
| Hypercalciuria, Hypophosphatemic Rickets | SLC34A3 |
| Hyperglycinuria | SLC6A19 |
| Hyperglycinuria | SLC36A2 |
| Hyperglycinuria | SLC6A20 |
| Hyperinsulinemic Hypoglycemia, Diabetes Mellitus | ABCC8 |
| Hyperparathyroidism 2 | CDC73 |
| Hyperphenylalaninemia, BH4-De�cient | PCBD1 |
| Hyperphosphatemic Familial Tumoral Calcinosis | GALNT3 |
| Hyperphosphatemic Tumoral Calcinosis | KL |
| Hyperprolinemia, Type 1 | PRODH |
| Hyperuricemic Nephropathy | REN |
| Hyperuricemic Nephropathy | SARS2 |
| Hyperuricemic Nephropathy | UMOD |
| Hypocalciuric Hypercalcemia, Familial | AP2S1 |
| Hypocalciuric Hypercalcemia, Familial | CASR |
| Hypocalciuric Hypercalcemia, Familial | GNA11 |
| Hypocalcemia | CASR |
| Hypogonadotropic hypogonadism 1 | ANOS1 |
| Hypokalemic Periodic Paralysis, Type 1, 2 | CACNA1S |
| Hypokalemic Periodic Paralysis, Type 1, 2 | SCN4A |
| Hypomagnesemia Type 1-6 | CLDN16 |
| Hypomagnesemia Type 1-6 | CLDN19 |
| Hypomagnesemia Type 1-6 | CNNM2 |
| Hypomagnesemia Type 1-6 | CNNM2 |
| Hypomagnesemia Type 1-6 | EGF |
| Hypomagnesemia Type 1-6 | FXYD |
| Hypomagnesemia Type 1-6 | KCNA1 |
| Hypomagnesemia Type 1-6 | TRPM6 |
| Hypoparathyroidism, Familial Isolated | GCM2 |
| Hypoparathyroidism, Sensorineural Deafness, and Renal Dysplasia | GATA3 |
| Hypophosphatasia | ALPL |
| Hypophosphatemic Rickets | CLCN5 |
| Hypophosphatemic Rickets | DMP1 |
| Hypophosphatemic Rickets | ENPP1 |
| Hypophosphatemic Rickets | FGF23 |
| Hypophosphatemic Rickets | PHEX |
| Hypophosphatemic Rickets | VDR |
| Hypotrichosis-Lymphedema- Telangiectasia-Renal Defect Syndrome | SOX18 |
| Hypouricemia, Renal, Type 1, 2 | SLC22A12 |
| Hypouricemia, Renal, Type 1, 2 | SLC2A9 |
| IMAGE Syndrome | CDKN1C |
| Interstitial Lung Disease with Nephrotic Syndrome and Epidermolysis Bullosa | ITGA3 |
| ITGA3 | FAN1 |
| IPEX Syndrome | FOXP3 |
| Isolated Renal Hypoplasia | PAX2 |
| IVIC Syndrome | SALL4 |
| Joubert Syndrome Type 3, 4, 5, 6, 10 with Oculoreneal Defect | AHI1 |
| Joubert Syndrome Type 3, 4, 5, 6, 10 with Oculoreneal Defect | CEP290 |
| Joubert Syndrome Type 3, 4, 5, 6, 10 with Oculoreneal Defect | NPHP1 |
| Joubert Syndrome Type 3, 4, 5, 6, 10 with Oculoreneal Defect | OFD1 |
| Joubert Syndrome Type 3, 4, 5, 6, 10 with Oculoreneal Defect | TMEM67 |
| Junctional Epidermolysis Bullosa- Pyloric Atresia Syndrome | ITGA6 |
| Junctional Epidermolysis Bullosa- Pyloric Atresia Syndrome | ITGB4 |
| Kallmann Syndrome | ANOS1 |
| Kallmann Syndrome | FGFR1 |
| Kallmann Syndrome | PROKR2 |
| Kelley-Seegmiller Syndrome | HPRT1 |
| Koolen-De Vries Syndrome | KANSL1 |
| LADD Syndrome | FGF10 |
| LADD Syndrome | FGFR2 |
| Lesch-Nyhan Syndrome | HPRT1 |
| Liddle Syndrome, Type 1, 2 | SCNN1B |
| Liddle Syndrome, Type 1, 2 | SCNN1G |
| Lipodystrophy Congenital Generalized, Type 1, 2, 3 | AGPAT2 |
| Lipodystrophy Congenital Generalized, Type 1, 2, 3 | BSCL2 |
| Lipodystrophy Congenital Generalized, Type 1, 2, 3 | CAV1 |
| Lipodystrophy, Familial Partial, Type 7 | CAV1 |
| Lipoid Adrenal Hyperplasia | STAR |
| Lipoprotein Glomerulopathy | APOE |
| LMNA-Related Disorders | LMNA |
| Lowe Syndrome | OCRL |
| LRP5-Related Disorders | LRP5 |
| Lymphedema-Distichiasis Syndrome with Renal Disease and Diabetes Mellitus | FOXC2 |
| Lysinuric Protein Intolerance | SLC7A7 |
| Mandibulfacial Dysostosis with Alopecia | EDNRA |
| Maturity Onset Diabetes of the Young (MODY), Type 2-4, 6-9, 11 | BLK |
| Maturity Onset Diabetes of the Young (MODY), Type 2-4, 6-9, 11 | CEL |
| Maturity Onset Diabetes of the Young (MODY), Type 2-4, 6-9, 11 | GCK |
| Maturity Onset Diabetes of the Young (MODY), Type 2-4, 6-9, 11 | HNF1A |
| Maturity Onset Diabetes of the Young (MODY), Type 2-4, 6-9, 11 | KLF11 |
| Maturity Onset Diabetes of the Young (MODY), Type 2-4, 6-9, 11 | NEUROD1 |
| Maturity Onset Diabetes of the Young (MODY), Type 2-4, 6-9, 11 | PAX4 |
| Maturity Onset Diabetes of the Young (MODY), Type 2-4, 6-9, 11 | PDX1 |
| Meckel Syndrome, Type 3,4,7 | CEP290 |
| Meckel Syndrome, Type 3,4,7 | NPHP3 |
| Meckel Syndrome, Type 3,4,7 | TMEM67 |
| Medullary Cystic Kidney Disease | UMOD |
| Megaloblastic Anemia 1 | CUBN |
| Megaloblastic Anemia 1 | AMN |
| Metaphyseal Chondrodysplasia, Murk Jansen Type | PTH1R |
| Methylmalonic Acidemia, Type mut0 | MUT |
| Methylmalonic Aciduria and Homocystinuria, Type cblC | MMACHC |
| Mevalonic Aciduria | MVK |
| Microphthalmia, syndromic 6 | BMP4 |
| Mitochondrial Complex 3 Deficiency | BCS1L |
| Mitochondrial Complex 3 Deficiency | UQCC2 |
| Mitochondrial Complex 4 De�ciency | APOPT1 |
| Mitochondrial Complex 4 De�ciency | (COA8) |
| Mitochondrial Complex 4 De�ciency | COX10 |
| Mitochondrial Complex 4 De�ciency | COX14 |
| Mitochondrial Complex 4 De�ciency | COX20 |
| Mitochondrial Complex 4 De�ciency | COX6B1 |
| Mitochondrial Complex 4 De�ciency | COX8A |
| Mitochondrial Complex 4 De�ciency | FASTKD2 |
| Mitochondrial Complex 4 De�ciency | PET100 |
| Mitochondrial Complex 4 De�ciency | SCO1 |
| Mitochondrial Complex 4 De�ciency | TACO1 |
| Mitochondrial DNA Depletion Syndrome 8A | RRM2B |
| Muckle-Wells Syndrome | NLRP3 |
| Mullerian Aplasia and Hyperandrogenism | WNT4 |
| Multicentric Carpotarsal Osteolysis with or without Nephropathy | MAFB |
| Myoglobinuria, Acute Recurrent | LPIN1 |
| Nail-Patella Syndrome | LMX1B |
| Nephrolithiasis | CLCN5 |
| Nephrolithiasis | FGF23 |
| Nephrolithiasis | SLC26A1 |
| Nephrolithiasis/Osteoporosis,Hypophosphatemic 1 and 2 | SLC34A1 |
| Nephrolithiasis/Osteoporosis,Hypophosphatemic 1 and 2 | SLC9A3R1 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | ANKS6 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | CEP164 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | DCDC2 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | GLIS2 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | INVS |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | NEK8 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | NPHP1 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | NPHP3 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | NPHP4 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | SLC41A1 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | TMEM67 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | TTC21B |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | WDR19 |
| Nephronophthisis 1–4, 7, 9, 11–13, 15, 16, 19 | XPNPEP3 |
| Nephropathy due to CFHR5 Deficiency | CFHR5 |
| Nephropathy with Pretibial Epidermolysis Bullosa and Deafness | CD151 |
| Nephrotic Syndrome | DLC1 |
| Nephrotic Syndrome | ITSN2 |
| Nephrotic Syndrome | KANK1 |
| Nephrotic Syndrome | TNS2 |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | DGKE |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | LAMB2 |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | MAGI2 |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | NPHS1 |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | NPHS2 |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | PLCE1 |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | PLCG2 |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | PTPRO |
| Nephrotic Syndrome Type 2-7, 15, Steroid sensitive, Congenital | WT1 |
| Neuro�bromatosis, Type 1 | NF1 |
| Noonan Syndrome | BRAF |
| Noonan Syndrome | PTPN11 |
| Norum Disease | LCAT |
| Obesity | MC4R |
| Obesity | UCP3 |
| Ochoa Syndrome | HPSE2 |
| Orofaciodigital Syndrome 6, I | CPLANE1 |
| Orofaciodigital Syndrome 6, I | OFD1 |
| Pallister-Hall Syndrome | GLI3 |
| Papillorenal Syndrome | PAX2 |
| Permanent Neonatal Diabetes Mellitus | INS |
| Permanent Neonatal Diabetes Mellitus | KCNJ11 |
| Pfeiffer Syndrome Type 3 | FGFR2 |
| Phosphoglycerate Kinase 1 Deficiency | PGK1 |
| Phosphoribosylpyrophosphate Synthetase Superactivity | PRPS1 |
| Pierson Syndrome | LAMB2 |
| Plasminogen De�ciency, Type 1 | PLG |
| Polycystic Kidney and/or Polycystic Liver Disease | ALG9 |
| Polycystic Kidney and/or Polycystic Liver Disease | GANAB |
| Polycystic Kidney Disease (PKD), 1 and 2, Autosomal Dominant | PKD1 |
| Polycystic Kidney Disease (PKD), 1 and 2, Autosomal Dominant | PKD2 |
| Polycystic Kidney Disease, Autosomal Recessive | PKHD1 |
| Polycystic Liver Disease (PLD), 1–3 | ALG8 |
| Polycystic Liver Disease (PLD), 1–3 | PRKCSH |
| Polycystic Liver Disease (PLD), 1–3 | SEC63 |
| Primary Hyperoxaluria Type 1, 2, 3 | AGXT |
| Primary Hyperoxaluria Type 1, 2, 3 | GRHPR |
| Primary Hyperoxaluria Type 1, 2, 3 | HOGA1 |
| Prune Belly Syndrome | CHRM3 |
| Pseudohypoaldosteronism Type I, Autosomal Dominant Hypertension, Early-Onse | NR3C2 |
| Pseudohypoaldosteronism,Type 1, 1B, 2B, 2C, 2D, 2E | CUL3 |
| Pseudohypoaldosteronism,Type 1, 1B, 2B, 2C, 2D, 2E | KLHL3 |
| Pseudohypoaldosteronism,Type 1, 1B, 2B, 2C, 2D, 2E | SCNN1A |
| Pseudohypoaldosteronism,Type 1, 1B, 2B, 2C, 2D, 2E | SCNN1B |
| Pseudohypoaldosteronism,Type 1, 1B, 2B, 2C, 2D, 2E | SCNN1G |
| Pseudohypoaldosteronism,Type 1, 1B, 2B, 2C, 2D, 2E | WNK1 |
| Pseudohypoaldosteronism,Type 1, 1B, 2B, 2C, 2D, 2E | WNK4 |
| Pseudohypoparathyroidism Type 1B | GNAS |
| Pseudohypoparathyroidism Type 1B | STX16 |
| Pseudoxanthoma Elasticum Arterial Calci�cation, Generalized, of Infancy, 2 | ABCC6 |
| Pulmonary Hypertension, Familial Primary with or without Hereditary Hemorrhagic Telangiectasia | BMPR2 |
| Pulmonary Hypertension, Primary 2, 3, 4 | CAV1 |
| Pulmonary Hypertension, Primary 2, 3, 4 | KCNK3 |
| Pulmonary Hypertension, Primary 2, 3, 4 | SMAD9 |
| Pulmonary venoocclusive disease 1 | BMPR2 |
| Renal Agenesis | RET |
| Renal Cysts and Diabetes Syndrome | HNF1B |
| Renal Dysplasia, Cystic | BICC1 |
| Renal Glucosuria | SLC5A1 |
| Renal Glucosuria | SLC5A2 |
| Renal Hypertension | SLC12A2 |
| Renal Hypodysplasia | SIX2 |
| Renal Hypodysplasia | UPK3A |
| Renal Tubular Acidosis | ATP6V0A4 |
| Renal Tubular Acidosis | ATP6V1B1 |
| Renal Tubular Acidosis | CA2 |
| Renal Tubular Acidosis | FOXI1 |
| Renal Tubular Acidosis | SLC4A1 |
| Renal Tubular Acidosis | SLC4A4 |
| Renal Tubular Acidosis | WDR72 |
| Renal Tubular Disease | NEDD4L |
| Renal Tubular Dysgenesis | ACE |
| Renal Tubular Dysgenesis | AGT |
| Renal Tubular Dysgenesis | AGTR1 |
| Renal Tubular Dysgenesis | REN |
| Renal-Hepatic-Pancreatic Dysplasia 2 | NEK8 |
| Rickets due to Defect in Vitamin D 25-hydroxylation | CYP2R1 |
| Robinow Syndrome | WNT5A |
| Robinow Syndrome | ROR2 |
| Rubinstein-Taybi Syndrome, Type 1 | CREBBP |
| Scalp-Ear-Nipple Syndrome | KCTD1 |
| Schimke Immunoosseous Dysplasia | SMARCAL1 |
| Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, and SeSAME Syndrome | KCNJ10 |
| Senior-Loken Syndrome,Type 4, 5, 6, 7 | CEP290 |
| Senior-Loken Syndrome,Type 4, 5, 6, 7 | INVS |
| Senior-Loken Syndrome,Type 4, 5, 6, 7 | IQCB1 |
| Senior-Loken Syndrome,Type 4, 5, 6, 7 | NPHP1 |
| Senior-Loken Syndrome,Type 4, 5, 6, 7 | NPHP3 |
| Senior-Loken Syndrome,Type 4, 5, 6, 7 | NPHP4 |
| Senior-Loken Syndrome,Type 4, 5, 6, 7 | SDCCAG8 |
| Senior-Loken Syndrome,Type 4, 5, 6, 7 | WDR19 |
| SERKAL Syndrome | WNT4 |
| Short Stature, Microcephaly, and Endocrine Dysfunction | XRCC4 |
| Short-Rib Thoracic Dysplasia | IFT140 |
| Short-Rib Thoracic Dysplasia | IFT172 |
| Short-Rib Thoracic Dysplasia | WDR19 |
| Simpson-Golabi-Behmel Syndrome, Type 1 | GPC3 |
| Smith-Lemli-Opitz Syndrome | DHCR7 |
| Sneddon Syndrome | ADA2 |
| Sotos Syndrome 1 | NSD1 |
| Steroid-Resistant Nephrotic Syndrome | ALG13 |
| Steroid-Resistant Nephrotic Syndrome | SYNPO |
| Steroid-Resistant Nephrotic Syndrome with Focal Segmental Hyalinosis | ARHGAP24 |
| Sucrase-Isomaltase De�ciency | SI |
| Susceptibility to End-Stage Renal Disease | APOL1 |
| Susceptibility to Gout | ABCG2 |
| Susceptibility to Hypertension | STK39 |
| Systemic Lupus Erythematosus 16 | DNASE1L3 |
| Thrombophilia due toThrombomodulin Defect | THBD |
| Thrombotic Thrombocytopenic Purpura, Familia | ADAMTS13 |
| Townes-Brocks Syndrome 1 | SALL1 |
| Tuberous Sclerosis 1, 2 | TSC1 |
| Tuberous Sclerosis 1, 2 | TSC2 |
| Tubulointerstitial Kidney Disease, Autosomal Dominant | HNF1B |
| Tubulointerstitial Kidney Disease, Autosomal Dominant | REN |
| Tubulointerstitial Kidney Disease, Autosomal Dominant | UMOD |
| Tumoral Calcinosis, Hyperphosphatemic | FGF23 |
| Thyrotoxic periodic paralysis, susceptibility to, Type 2 | KCNJ18 |
| Type 1 Diabetes | FOXP3 |
| Type 1 Diabetes | INS |
| Urofacial Syndrome 1 | HPSE2 |
| VACTERL association with hydrocephalus | HOXD13 |
| Vasculitis, Autoin�ammation, Immunode�ciency, and Hematologic Defects Syndrom | ADA2 |
| Vesicoureteral Re�ux 3 | SOX17 |
| Vitamin D-Dependent Rickets, Type 1A | CYP27B1 |
| Von Hippel-Lindau Syndrome | VHL |
| Wilson Disease | ATP7B |
| Wiskott-Aldrich Syndrome | WAS |
| Wolcott-Rallison Syndrome | EIF2AK3 |
| Wolfram Syndrome Type 1, 2 | CISD2 |
| Wolfram Syndrome Type 1, 2 | WFS1 |
| Xanthinuria, Type 1, 2 | MOCOS |
| Xanthinuria, Type 1, 2 | XDH |
File details come from the government source that posted it. Updated .